219 related articles for article (PubMed ID: 25108642)
1. Catechol-O-methyltransferase Val158Met polymorphism: modulation of wearing-off susceptibility in a Chinese cohort of Parkinson's disease.
Wu H; Dong F; Wang Y; Xiao Q; Yang Q; Zhao J; Quinn TJ; Chen SD; Liu J
Parkinsonism Relat Disord; 2014 Oct; 20(10):1094-6. PubMed ID: 25108642
[TBL] [Abstract][Full Text] [Related]
2. Association of COMT Val158Met polymorphism with wearing-off susceptibility in Parkinson's disease.
Liu J; Chen P; Guo M; Lu L; Li L
Neurol Sci; 2015 Apr; 36(4):621-3. PubMed ID: 25367407
[TBL] [Abstract][Full Text] [Related]
3. Catechol-O-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson's disease.
Zhang Y; Feng S; Nie K; Zhao X; Gan R; Wang L; Zhao J; Tang H; Gao L; Zhu R; Wang L; Zhang Y
J Neurol Sci; 2016 Oct; 369():347-353. PubMed ID: 27653922
[TBL] [Abstract][Full Text] [Related]
4. Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population.
Hao H; Shao M; An J; Chen C; Feng X; Xie S; Gu Z; Chan P;
Parkinsonism Relat Disord; 2014 Oct; 20(10):1041-5. PubMed ID: 25034874
[TBL] [Abstract][Full Text] [Related]
5. COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations.
Wang YC; Zou YB; Xiao J; Pan CD; Jiang SD; Zheng ZJ; Yan ZR; Tang KY; Tan LM; Tang MS
Neurol Res; 2019 Apr; 41(4):319-325. PubMed ID: 30644790
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic denervation severity depends on COMT Val158Met polymorphism in Parkinson's disease.
Muellner J; Gharrad I; Habert MO; Kas A; Martini JB; Cormier-Dequaire F; Tahiri K; Vidailhet M; Meier N; Brice A; Schuepbach M; Mallet A; Hartmann A; Corvol JC
Parkinsonism Relat Disord; 2015 May; 21(5):471-6. PubMed ID: 25753458
[TBL] [Abstract][Full Text] [Related]
7. Catechol-O-methyltransferase Val158Met and the risk of dyskinesias in Parkinson's disease.
de Lau LM; Verbaan D; Marinus J; Heutink P; van Hilten JJ
Mov Disord; 2012 Jan; 27(1):132-5. PubMed ID: 22083803
[TBL] [Abstract][Full Text] [Related]
8. Association study of catechol-O-methyltransferase (COMT) gene Val158Met polymorphism with auditory P300 in Chinese Han patients with schizophrenia.
Kang C; Xu X; Liu H; Yang J
Psychiatry Res; 2010 Dec; 180(2-3):153-5. PubMed ID: 20483173
[TBL] [Abstract][Full Text] [Related]
9. Catechol-O-methyltransferase gene Val158Met polymorphism and obsessive compulsive disorder susceptibility: a meta-analysis.
Kumar P; Rai V
Metab Brain Dis; 2020 Feb; 35(2):241-251. PubMed ID: 31879835
[TBL] [Abstract][Full Text] [Related]
10. Val158Met polymorphism of COMT gene and Parkinson's disease risk in Asians.
Chuan L; Gao J; Lei Y; Wang R; Lu L; Zhang X
Neurol Sci; 2015 Jan; 36(1):109-15. PubMed ID: 25060648
[TBL] [Abstract][Full Text] [Related]
11. Association of Catechol-O-Methyltransferase Gene rs4680 Polymorphism and Levodopa Induced Dyskinesia in Parkinson's Disease: A Meta-Analysis and Systematic Review.
Dwivedi A; Dwivedi N; Kumar A; Singh VK; Pathak A; Chaurasia RN; Mishra VN; Mohanty S; Joshi D
J Geriatr Psychiatry Neurol; 2023 Mar; 36(2):98-106. PubMed ID: 35603896
[TBL] [Abstract][Full Text] [Related]
12. The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism.
Klebe S; Golmard JL; Nalls MA; Saad M; Singleton AB; Bras JM; Hardy J; Simon-Sanchez J; Heutink P; Kuhlenbäumer G; Charfi R; Klein C; Hagenah J; Gasser T; Wurster I; Lesage S; Lorenz D; Deuschl G; Durif F; Pollak P; Damier P; Tison F; Durr A; Amouyel P; Lambert JC; Tzourio C; Maubaret C; Charbonnier-Beaupel F; Tahiri K; Vidailhet M; Martinez M; Brice A; Corvol JC; ;
J Neurol Neurosurg Psychiatry; 2013 Jun; 84(6):666-73. PubMed ID: 23408064
[TBL] [Abstract][Full Text] [Related]
13. The association between COMT Val158Met polymorphism and migraine risk: A meta-analysis.
Liao YJ; Jiang JR; Jin SQ
Cephalalgia; 2017 May; 37(6):592-598. PubMed ID: 27154995
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the Association between Catechol-O-Methyltransferase Val158Met and Male Sexual Orientation.
Yu W; Tu D; Hong F; Wang J; Liu X; Cai Y; Xu R; Zhao G; Wang F; Pan H; Wu S; Feng T; Wang B
J Sex Med; 2015 Sep; 12(9):1920-6. PubMed ID: 26346727
[TBL] [Abstract][Full Text] [Related]
15. The COMT Val158Met polymorphism affects the response to entacapone in Parkinson's disease: a randomized crossover clinical trial.
Corvol JC; Bonnet C; Charbonnier-Beaupel F; Bonnet AM; Fiévet MH; Bellanger A; Roze E; Meliksetyan G; Ben Djebara M; Hartmann A; Lacomblez L; Vrignaud C; Zahr N; Agid Y; Costentin J; Hulot JS; Vidailhet M
Ann Neurol; 2011 Jan; 69(1):111-8. PubMed ID: 21280081
[TBL] [Abstract][Full Text] [Related]
16. Association between catechol-O-methyltransferase gene polymorphisms and wearing-off and dyskinesia in Parkinson's disease.
Watanabe M; Harada S; Nakamura T; Ohkoshi N; Yoshizawa K; Hayashi A; Shoji S
Neuropsychobiology; 2003; 48(4):190-3. PubMed ID: 14673217
[TBL] [Abstract][Full Text] [Related]
17. Planning ability in Parkinson's disease is influenced by the COMT val158met polymorphism.
Foltynie T; Goldberg TE; Lewis SG; Blackwell AD; Kolachana BS; Weinberger DR; Robbins TW; Barker RA
Mov Disord; 2004 Aug; 19(8):885-91. PubMed ID: 15300652
[TBL] [Abstract][Full Text] [Related]
18. Association of the Val158Met catechol O-methyltransferase genetic polymorphism with panic disorder.
Rothe C; Koszycki D; Bradwejn J; King N; Deluca V; Tharmalingam S; Macciardi F; Deckert J; Kennedy JL
Neuropsychopharmacology; 2006 Oct; 31(10):2237-42. PubMed ID: 16525418
[TBL] [Abstract][Full Text] [Related]
19. G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease.
Xie T; Ho SL; Li LS; Ma OC
Mov Disord; 1997 May; 12(3):426-7. PubMed ID: 9159741
[TBL] [Abstract][Full Text] [Related]
20. Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence.
Lohoff FW; Weller AE; Bloch PJ; Nall AH; Ferraro TN; Kampman KM; Pettinati HM; Oslin DW; Dackis CA; O'Brien CP; Berrettini WH
Neuropsychopharmacology; 2008 Dec; 33(13):3078-84. PubMed ID: 18704099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
